Compounds > tocainide
Page last updated: 2024-08-23

tocainide and Disease Models, Animal

tocainide has been researched along with Disease Models, Animal in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Braisted, J; Dranchak, P; Earnest, TW; Gu, X; Hoon, MA; Inglese, J; Oliphant, E; Solinski, HJ1
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV1
Blackburn-Munro, G; Erichsen, HK; Hao, JX; Xu, XJ1
Camerino, DC; Corbo, F; De Luca, A; Desaphy, JF; Didonna, MP; Ferrannini, E; Franchini, C; Jockusch, H; Lentini, G; Liantonio, A; Natuzzi, F; Pierno, S; Tortorella, V1
Bryant, SH; Camerino, DC; De Luca, A; Pierno, S1

Other Studies

5 other study(ies) available for tocainide and Disease Models, Animal

ArticleYear
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
    Science translational medicine, 2019, 07-10, Volume: 11, Issue:500

    Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, Spinal; Humans; Mice, Inbred C57BL; Mice, Knockout; Neurons; Pruritus; Receptors, Atrial Natriuretic Factor; Reproducibility of Results; Signal Transduction; Small Molecule Libraries

2019
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

    Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection

2020
A comparison of the antinociceptive effects of voltage-activated Na+ channel blockers in two rat models of neuropathic pain.
    European journal of pharmacology, 2003, Jan-05, Volume: 458, Issue:3

    Topics: Analgesics; Analysis of Variance; Anesthetics, Local; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Hindlimb; Lamotrigine; Lidocaine; Male; Mexiletine; Neuralgia; Pain Measurement; Rats; Rats, Sprague-Dawley; Sodium Channel Blockers; Sodium Channels; Time Factors; Tocainide; Triazines

2003
New potent mexiletine and tocainide analogues evaluated in vivo and in vitro as antimyotonic agents on the myotonic ADR mouse.
    Neuromuscular disorders : NMD, 2004, Volume: 14, Issue:7

    Topics: Action Potentials; Analysis of Variance; Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Electric Conductivity; Electromyography; Female; In Vitro Techniques; Inhibitory Concentration 50; Male; Mexiletine; Mice; Mice, Mutant Strains; Muscle Contraction; Myotonic Disorders; Patch-Clamp Techniques; Sodium Channels; Structure-Activity Relationship; Time Factors; Tocainide

2004
Antimyotonic effects of tocainide enantiomers on skeletal muscle fibers of congenitally myotonic goats.
    Neuromuscular disorders : NMD, 2000, Volume: 10, Issue:3

    Topics: Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Female; Goats; Male; Muscle Fibers, Skeletal; Muscle, Skeletal; Myotonia Congenita; Stereoisomerism; Tocainide

2000